This webinar will provide an overview of the Advanced Bioscience of Viral Products (ABViP), a BBSRC collaborative training partnership offering industry and academic DPhil/PhD opportunities.
The funded four-year doctoral training programme led by Oxford Biomedica along with our partners the University of Oxford and UCL is focused on advancing research of viral products for future gene therapies and vaccines.
Student applications are now open and successful applicants for our final cohort, who will start their studies in September/October 2024. Join our webinar and discover more about this unique training opportunity that will provide insight into research and development activities from both an academic and industrial perspective.
Presenters: Representatives from Oxford Biomedica, the University of Oxford and UCL